NURS FPX 4030 Assessment 2
Phillip September 15, 2023 No Comments

NURS FPX 4030 Assessment 2 – Determining the Credibility of Evidence and Resources

NURS FPX 4030 Assessment 2 – Determining the Credibility of Evidence and Resources

Student Name

Capella University

NURS FPX 4030: Making Evidence-Based Decisions



Type 2 Diabetes and Evidence-based Practice

Type 2 Diabetes (T2D) presents a significant health challenge and an evidence-based approach is crucial for optimizing disease management strategies. Unchecked diabetes can lead to severe health complications and reduced quality of life, even resulting in mortality. The National Institute for Health and Care Excellence (NICE), American Diabetes Association (ADA), and World Health Organization (WHO) guidelines offer comprehensive evidence-based care approaches, encompassing lifestyle changes, drug therapy, glycemic control, screening for complications, and managing comorbidities.

Determining the Credibility of Evidence and Resources

Implementing evidence-based practice (EBP) in the management of type 2 diabetes brings significant benefits as it allows for the application of the latest, high-quality research, ensuring current and accurate management strategies. Importantly, EBP supports individualized patient care, integrating patient preferences with clinical expertise and the best available evidence for an optimal outcome (ADA, 2021; NICE, 2021). Furthermore, the World Health Organization (2021) elaborates that evidence-based practices in healthcare settings promote standardized care, reduce variability and enhance consistency in clinical decision-making. There are several studies that support evidence-based practice in the healthcare sector. One of the studies promotes the adoption of EBP as it helps healthcare providers to enhance their health practice, which increases the likelihood of improved health outcomes (Wiviott et al., 2019). These supporting studies conclude that an evidence-based approach is critical and beneficial in managing various healthcare conditions, especially type II diabetes in the context of this paper. 

Criteria to Analyze the Credibility of the Resources

The CRAAP criteria come in handy when you want to evaluate how trustworthy sources like journal articles and websites are. It consists of five elements: Currency, Relevance, Authority, Accuracy, and Purpose. Currency pertains to the freshness of information, involving inquiring about the publication or posting date and whether any updates or revisions have occurred. Relevance considers whether the information is important for your needs and whether it relates to your topic appropriately. Authority pays close attention to where the information originates from, taking into account the author’s background and affiliations. It considers whether the authors are experts in their field. Accuracy refers to how trustworthy and truthful the information is, considering factors such as whether there’s supporting evidence for it and if experts have reviewed or edited it. The essence of purpose lies in understanding why the information is present – whether its goal is to educate, enlighten, market, amuse, or convince. This inquiry also involves scrutinizing any potential prejudices, be they political, ideological, cultural, religious, institutional, or individual (Lowe et al., 2021). One specific resource that fits the CRAAP criteria is from the website of the World Health Organization.

World Health Organization. (2021). Global report on diabetes. 4

 This resource on type 2 diabetes offers high credibility when evaluated using the CRAAP criteria as the information is updated currently using the latest research. Moreover, WHO is an international authority in public health and offers highly relevant information on type 2 diabetes. Its guidelines demonstrate accuracy, corroborated by extensive deep research and scientific rigor. Finally, the purpose of these guidelines is straightforward and aligns with WHO’s mission to provide unbiased, evidence-based guidance to improve global health outcomes. Thus, the WHO’s type 2 diabetes guidelines pass the CRAAP test, affirming their credibility and suitability for informing evidence-based practice.

Credibility and Relevance of Evidence and Resources

Three specific resources related to Type 2 Diabetes were analyzed for their credibility and relevance. The first resource is the American Diabetes Association (2021) “Standards of Medical Care in Diabetes Abridged for Primary Care Providers.” This resource is considered highly credible and relevant due to its extensive review process, use of the latest research, and endorsement by a leading professional body in diabetes care. It contains comprehensive clinical recommendations and guidelines for evidence-based practice. The second resource is the National Institute for Health and Care Excellence (2021) “Type 2 diabetes in adults: Management” guideline. Produced by a reputable health authority, this resource is also highly credible and practical for Type 2 diabetes management. It offers evidence-based recommendations covering various aspects of diabetes care, including patient education, dietary advice, blood glucose level management, and treatment of complications.

The study by Wiviott et al. (2019) published in The Lancet is highly credible and relevant. This study’s credibility is supported by thorough research methodologies, rigorous peer-review processes, and its publication in a reputable journal. The critical finding proposes healthcare enhancements and better health outcomes for a significant population. Thus, the evidence provided is invaluable for healthcare providers in their continued efforts to apply evidence-based practice for optimal patient outcomes. Among these resources, the most useful one appears to be the American Diabetes Association (2021) “Standards of Medical Care in Diabetes Abridged for Primary Care Providers” due to its comprehensive nature, rigorous approach, and authority as a professional body’s endorsement. However, the relevance of each resource would depend on the specific parameters of the diagnosis and care context, as all resources offer valuable perspectives on different aspects of diabetes care.

The Importance of Evidence-based Practice Model

Embracing reliable sources in an evidence-based practice (EBP) model is crucial, particularly in managing chronic conditions like Type 2 diabetes. Credible evidence serves as factual support for selecting interventions and developing reliable care plans. The Iowa model for Evidence-based Practice is an example of an EBP model used to address Type 2 diabetes. It begins with identifying the problem of managing diabetes in newly diagnosed patients, where credible evidence helps understand current standards, potential complications, and contributing factors. Assessing the importance of the problem also relies on credible evidence to evaluate the severity of the issue, considering impacts on patients’ quality of life, morbidity, mortality rates, and associated costs. Building an interdisciplinary team for diabetes care requires each member’s expertise backed by credible evidence in their field, ensuring a comprehensive approach (Abu-Baker, 2021).

Determining the Credibility of Evidence and Resources

Using tools like the CRAAP (Currency, Relevance, Authority, Accuracy, and Purpose) criteria to find credible and reliable information is essential to ensure that the EBP model is based on up-to-date, accurate, and relevant evidence. This may include the latest research on diabetes management, newly approved medications, or promising lifestyle interventions. Implementing changes within the organization also necessitates evidence, such as the best practices for implementation or validation of proposed interventions. Lastly, analyzing the results to assess the effectiveness of the implemented change relies on collecting and interpreting reliable data, highlighting the importance of credible evidence throughout the EBP process. In general, trustworthy proof forms a solid base for every stage of the EBP process, guaranteeing that choices about patient care are influenced by the finest existing proof. This enhances the standard of care, and patient well-being, and makes certain that patients get the most fitting and current treatments.


In summary, research based on evidence is extremely important to support clinical decisions and practices, often referred to as evidence-based practices. Models such as the Iowa model play a vital part in assisting healthcare professionals in dealing with complex health issues like Type 2 Diabetes, which remain a significant challenge in terms of both illness and death. The structured approach of these evidence-based practice models aids in the recognition, assessment, and application of trustworthy and dependable resources. NURS FPX 4030 Assessment 2 – Determining the Credibility of Evidence and Resources. This enhances the ability to think critically and make decisions in clinical environments. The implementation of these approaches not only benefits the knowledge and professional development of healthcare providers but also significantly enhances the quality of patient-centered care. Ultimately, evidence-based practices have a profound impact on healthcare results and patient experiences, highlighting their essential role in modern healthcare.


Abu-Baker, N. N., AbuAlrub, S., Obeidat, R. F., & Assmairan, K. (2021). Evidence-based practice beliefs and implementations: A cross-sectional study among undergraduate nursing students. BMC Nursing20(1).  

American Diabetes Association. (2021). Standards of Medical Care in Diabetes: Abridged for Primary Care Providers. Clin. Diabetes, 39(1), 14–43. 2

Lowe, M. S., Macy, K. V., Murphy, E., & Kani, J. (2021). Questioning Craap. Journal of the Scholarship of Teaching and Learning21(3). 

NURS FPX 4030 Assessment 2 – Determining the Credibility of Evidence and Resources

National Institute for Health and Care Excellence. (2021). Type 2 diabetes in adults: Management. 3

Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., Ruff, C. T., Gause-Nilsson, I. A. M., Fredriksson, M., Johansson, P. A., Langkilde, A.M. (2019). Dapagliflozin and cardiovascular outcomes in type 2 diabetes. The New England Journal of Medicine, 380(4), 347–357. 

NURS FPX 4030 Assessment 2 – Determining the Credibility of Evidence and Resources

World Health Organization. (2021). Global report on diabetes. 4